tiprankstipranks
Supernus Pharmaceuticals (GB:0LB2)
NASDAQ:0LB2
UK Market

Supernus Pharmaceuticals (0LB2) Technical Analysis

0 Followers

Technical Sentiment

Overall Consensus
Strong Sell
1Bullish
0Neutral
12Bearish
Technical Analysis Consensus
Strong Sell
0Bullish
0Neutral
1Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Supernus Pharmaceuticals’s (0LB2) Moving Averages Convergence Divergence (MACD) indicator is 0.49, suggesting Supernus Pharmaceuticals is a Sell.
Supernus Pharmaceuticals’s (0LB2) 20-Day exponential moving average is 47.49, while Supernus Pharmaceuticals’s (0LB2) share price is $47.68, making it a Sell.
Supernus Pharmaceuticals’s (0LB2) 50-Day exponential moving average is 47.44, while Supernus Pharmaceuticals’s (0LB2) share price is $47.68, making it a Sell.

Supernus Pharmaceuticals (0LB2) Pivot Points

Aug 02, 2026, 01:18 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
Fibonacci
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Supernus Pharmaceuticals (0LB2) Moving Averages

Aug 02, 2026, 01:18 PM
Period
Simple
Exponential
MA5
47.52Sell
47.36Sell
MA10
47.88Sell
47.59Sell
MA20
47.85Sell
47.49Sell
MA50
46.55Buy
47.44Sell
MA100
48.39Sell
47.95Sell
MA200
49.05Sell
47.84Sell
Supernus Pharmaceuticals’s (0LB2) 10-Day exponential moving average is 47.59, while Supernus Pharmaceuticals’s (0LB2) share price is $47.68, making it a Sell.
Supernus Pharmaceuticals’s (0LB2) 100-Day exponential moving average is 47.95, while Supernus Pharmaceuticals’s (0LB2) share price is $47.68, making it a Sell.
Supernus Pharmaceuticals’s (0LB2) stock price is $47.68 and Supernus Pharmaceuticals’s (0LB2) 50-day simple moving average is 46.55, creating a Buy signal.
Supernus Pharmaceuticals’s (0LB2) stock price is $47.68 and Supernus Pharmaceuticals’s (0LB2) 100-day simple moving average is 48.39, creating a Sell signal.
Supernus Pharmaceuticals’s (0LB2) stock price is $47.68 and Supernus Pharmaceuticals’s (0LB2) 200-day simple moving average is 49.05, creating a Sell signal.

Supernus Pharmaceuticals (0LB2) Technical Indicators

Aug 02, 2026, 01:18 PM
Name
Value
Implied Action
RSI (14)
53.01
Neutral
STOCH (9,6)
67.26
Neutral
STOCHRSI (14)
38.66
Neutral
MACD (12,26)
0.49
Sell
ADX (14)
18.14
Buy
Williams %R
-72.06
Buy
CCI (14)
3.43
Neutral
ATR (14)
0.85
-
Ultimate Oscillator
67.97
Neutral
ROC
-2.54
Sell
Supernus Pharmaceuticals’s (0LB2) Relative Strength Index (RSI) is 53.01, creating a Neutral signal.
Supernus Pharmaceuticals’s (0LB2) Trend Strength Indicator (ADX) is 18.14, creating a Buy signal.
Supernus Pharmaceuticals’s (0LB2) Commodity Channel Index (CCI) is 3.43, creating a Neutral signal.
Supernus Pharmaceuticals’s (0LB2) Price Rate of Change (ROC) is -2.54, creating a Sell signal.

FAQ

Is 0LB2 a Buy, Hold, or Sell?
Based on 0LB2’s technical indicators, 0LB2 is a Strong Sell.
    What is 0LB2’s RSI (14)?
    0LB2’s RSI (14) is 53.01, which suggests 0LB2 is a Neutral.
      What is 0LB2’s MACD?
      0LB2’s MACD is 0.49, which suggests 0LB2 is a Sell.
        What is 0LB2’s 5-day moving average?
        0LB2’s 5-day moving average is 47.52, which suggests 0LB2 is a Sell.
          What is 0LB2’s 20-day moving average?
          0LB2 20-day moving average is 47.85, which suggests 0LB2 is a Sell.
            What is 0LB2’s 50-day moving average?
            0LB2’s 50-day moving average is 46.55, which suggests 0LB2 is a Buy.
              What is 0LB2’s 200-day moving average?
              0LB2’s 200-day moving average is 49.05, which suggests 0LB2 is a Sell.
                What is 0LB2’s Williams % R (14)?
                0LB2’s Williams % R (14) is -72.06, which suggests 0LB2 is a Buy.
                  What is 0LB2’s CCI (14)?
                  0LB2’s CCI (14) is 3.43, which suggests 0LB2 is a Neutral.
                    What is the share price of Supernus Pharmaceuticals?